CXCL8 and head and neck squamous cell carcinoma: Our findings reveal the molecular mechanism by which HNSCC tolerates a glucose-deficient microenvironment by educating TAMs, suggesting that targeting CXCL8 represents a promising therapeutic strategy to increase the efficacy of nutrient starvation therapies for HNSCC.